Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
Europe: Pharma industry denies it lobbied for medicines to move to DG Enterprise

Europe’s pharmaceutical industry has said it did not lobby for medicines and medical devices to be moved from the European Commission's health directorate (DG Sanco) to the enterprise directorate (DG Enterprise).

Published
01 October 2014
From
EurActiv
Exclusive: India set to run out of critical free drug for HIV/AIDS program

India could run out of a critical medicine in its free HIV/AIDS drugs program in three weeks due to bureaucratic bungling, a senior government official said, leaving more than 150,000 sufferers without life-saving drugs for about a month.

Published
01 October 2014
From
Reuters
J&J makes a splash in hep C with a $1.75B deal for Alios

Johnson & Johnson ($JNJ) is taking a deep dive into antivirals, trading $1.75 billion for private biotech Alios BioPharma to get its hands on a midstage treatment and some early assets that could expand its share of the blockbuster hepatitis C market.

Published
01 October 2014
From
Fierce Biotech
France uses tax to put pressure on hepatitis C drug prices

France will tax drugmakers whose costly hepatitis C drugs threaten to throw off course its healthcare budget, the government has said, heaping pressure on pharmaceutical companies like Gilead Sciences to cut their prices.

Published
01 October 2014
From
Reuters
UNITAID: Tuberculosis diagnostics technology and market landscape – 3rd edition

UNITAID releases today its 2014 Tuberculosis Diagnostics Technology and Market Landscape, detailing the promising pipeline of products and technologies to diagnose tuberculosis (TB). The report highlights current and emerging technologies from over 80 manufacturers and developers, including products which are smaller, simpler and easier to use.

Published
01 October 2014
From
EATG
PrEP will need high adherence, high effectiveness and high coverage in specific populations to be affordable in the US, New York study finds

A study based on New York City that modelled pre-exposure prophylaxis (PrEP) uptake there has found that in order to be affordable, PrEP would need to be

Published
01 October 2014
By
Gus Cairns
Selling the End of AIDS

As slogans anticipating an end to the AIDS epidemic gain popularity, skeptics worry that such promises are hollow and unrealistically ambitious, and that failure to deliver will ultimately set back efforts to combat HIV.

Published
01 October 2014
From
Poz
Late diagnosis of HIV blamed on Coalition's health reforms

Health experts are reporting disturbing increases in the number of people being diagnosed late with the HIV virus in England. They warn that healthcare reforms, which, they say, have "fragmented" a previously "seamless sexual health service", may be a major reason for the delays, and have called for an investigation.

Published
29 September 2014
From
The Independent
Only half of gay and bisexual men diagnosed with HIV received care and treatment in 2010

Among gay and bisexual men in the United States who have been diagnosed with HIV, only half are receiving care and treatment for their infection, according to a new analysis by the Centers for Disease Control and Prevention. And just 42 percent have achieved viral suppression – meaning their virus is under control at a level that helps keep them healthy and also greatly reduces their risk of transmitting HIV to others.

Published
29 September 2014
From
CDC press release
Patent landscape for hepatitis issued by WHO

The World Health Organization has published an analysis of the patent situation for new hepatitis treatments, and a call for possible pharmaceutical products for prequalification.

Published
29 September 2014
From
Intellectual Property Watch

Filter by country